Construction and characterization of an unmarked aroC deletion mutant of burkholderia pseudomallei strain A2

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 40, Issue 1, 2009, Pages 123-130

  Srilunchang, Thitima ^a   Proungvitaya, Tanakorn ^a   Wongratanacheewin, Surasak ^a   Strugnell, Richard ^b   Homchampa, Preecha ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 59149085035     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Atkins T, Prior RG, Mack K, et al. A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect Immun 2002; 70: 5290-4.
2. th ed. New York: Wiley, 1999.
3. Brett PJ, Woods DE. Pathogenesis of and immunity to melioidosis. Acta Trop 2000; 74: 201-10.
4. Chen YS, Hsiao YS, Lin HH, Yen CM, Chen SC, Chen YL. Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellin. Vaccine 2006; 24: 750-8.
5. Dance DA. Melioidosis as an emerging global problem. Acta Trop 2000; 74: 115-9.
6. Foulongne V, Walravens K, Bourg G, et al. Aromatic compound-dependent Brucella suis is attenuated in both cultured cells and mouse models. Infect Immun 2001; 69: 547-50.
7. Hoppe I, Brenneke B, Rohde M, et al. Characterization of a murine model of melioidosis: comparison of different strains of mice. Infect Immun 1999; 67: 2891-9.
8. Jeddeloh JA, Fritz DL, Waag DM, Hartings JM, Andrews GP. Biodefense-driven murine model of pneumonic melioidosis. Infect Immun 2003; 71: 584-7.
9. Lowe DC, Savidge TC, Pickard D, et al. Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in am A, aroC, and htrA. Infect Immun 1999; 67: 700-7.
10. Mohr CD, Tomich M, Herfst CA. Cellular aspects of Burkholderia cepacia infection. Microbes Infect 2001; 3: 425-35.
11. Pittard J, Wallace BJ. Distribution and function of genes concerned with aromatic biosynthesis in Escherichia coli. J Bacteriol 1966; 91: 1494-08.
12. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27: 493-7.
13. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13: 151-77.
14. rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2001.
15. Stevens MP, Haque A, Atkins T, et al. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology 2004; 150: 2669-76.
16. Warawa J, Woods DE. Melioidosis vaccines. Expert Rev Vaccines 2002; 1: 477-82.
17. White NJ. Melioidosis. Lancet 2003; 361: 1715-22.
18. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 2006; 4: 272-82.